You are here

Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Bilbao, , 48903 Spain
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Invasive Pneumococcal Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0-5
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- All children from 0 up to 5 years attending to the hospital's emergency department
will be evaluated for IPD.

- Diagnosis of IPD will be based on positive pneumococcal isolation in any sterile
location, such us blood or spinal fluid.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- All children from 0 up to 5 years attending to the hospital's emergency department
will be evaluated for IPD.

- Diagnosis of IPD will be based on positive pneumococcal isolation in any sterile
location, such us blood or spinal fluid.

NCT00227188
Pfizer
Completed
Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now